<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03540875</url>
  </required_header>
  <id_info>
    <org_study_id>2017/04</org_study_id>
    <nct_id>NCT03540875</nct_id>
  </id_info>
  <brief_title>Automated Anesthesia Guided by the Conox Monitor for Surgery</brief_title>
  <acronym>Conox-loop</acronym>
  <official_title>Comparison Between Manual Versus Closed-loop Titration of Propofol and Remifentanil Guided by the qCon and qNox Indexes During Induction and Maintenance of General Anesthesia in Adult Patients: a Multicentre Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CMC Ambroise Paré</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CMC Ambroise Paré</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares automated administration of propofol and remifentanil versus manual
      administration during general anesthesia for a surgery. The closed-loop coadministration of
      propofol and remifentanil is guided by qCon and qNox indexes from the Conox monitor.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several monitors are currently proposed to evaluate the depth of hypnosis. The Conox monitor
      differentiates itself from the other brain monitor by calculating two EEG indexes, the qCon
      and the qNox. The qCon corresponds to the depth of the sedation and the qNox relates to the
      probability that a nociceptive stimulation triggers a movement of the patient. A controller
      allowing the automated titration of propofol guided by the qCon and remifentanil guided by
      the qNox has been developed. In preparation for a large multi-center control trial, this
      prospective randomized study evaluates the effectiveness of such a closed-loop anesthesia
      system. Two groups of patients are compared: one arm in which propofol and remifentanil are
      administered by the anesthesiologist using target-controlled infusion (TCI) systems, and the
      second arm in which propofol and remifentanil are administered automatically by the combined
      closed-loop anesthesia system. In both groups, the goal is to maintain qCon between 40 and
      60, the recommended range during anesthesia by the manufacturer. It is expected the combined
      closed-loop anesthesia system group to do similar or better control to maintain the qCon in
      the desired range.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Update of the technical documentation of the device
  </why_stopped>
  <start_date type="Actual">July 2, 2018</start_date>
  <completion_date type="Anticipated">December 2, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adequate sedation</measure>
    <time_frame>Start of general anesthesia maintenance, i.e. qCon below 60 for 30 consecutive seconds for the first time, until the end of propofol et remifentanil infusion</time_frame>
    <description>Percentage of time with qCon index within the 40-60 range as recommended by the manufacturer of Conox monitor.
Data from the Conox monitor (signal quality index, qCon index, qNox index, Suppression ratio) are recorded every second.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adequate analgesia</measure>
    <time_frame>Start of general anesthesia maintenance, i.e. qNox below 60 for 30 consecutive seconds for the first time, until the end of propofol et remifentanil infusion</time_frame>
    <description>Percentage of time with qNox index within the 40-60 range as recommended by the manufacturer of Conox monitor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of Burst Suppression Ratio (bsr)</measure>
    <time_frame>Intraoperative period</time_frame>
    <description>Presence of Burst Suppression defined by a rate &gt; 10% for at least one minute</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dose of hypnotic drug</measure>
    <time_frame>Intraoperative period</time_frame>
    <description>Total amount of propofol during the induction and the maintenance of the anesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dose of analgesic drug</measure>
    <time_frame>Intraoperative period</time_frame>
    <description>Total amount of remifentanil during the induction and the maintenance of the anesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical interventions on the dosage of drugs</measure>
    <time_frame>Intraoperative period</time_frame>
    <description>Number of modifications of target of propofol and remifentanil</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic status</measure>
    <time_frame>Intraoperative period</time_frame>
    <description>Number of episodes of hemodynamic anomalies having required a treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluid therapy</measure>
    <time_frame>Intraoperative period</time_frame>
    <description>Intraoperative volume loading and transfusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delay before awakening</measure>
    <time_frame>12 hours</time_frame>
    <description>Delay between the cessation of infusion of propofol and remifentanil and extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Explicit memorization</measure>
    <time_frame>48 hours</time_frame>
    <description>Awareness standardized questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Anesthesia, General</condition>
  <arm_group>
    <arm_group_label>Full automation group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Full automation control of propofol and remifentanil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Manual control of of propofol and remifentanil using TCI system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Closed loop anesthesia</intervention_name>
    <description>Propofol and Remifentanil are administered automatically using a closed-loop system.
The goal of this study is to compare manual titration versus automated titration of propofol and remifentanil in adult patients undergoing surgery guided by the electro-cortical activity. The aim in both group is to maintain the qCon in the range 40-60 during induction and maintenance of general anesthesia using the propofol in TCI mode. But also the qNox in the range 40-60 using remifentanil. The controller is based on a Proportional-Integral-derivative algorithm which steers a target to the pumps during induction and maintenance of general anesthesia.</description>
    <arm_group_label>Full automation group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>The dosage is modified automatically by the device or according to the new medical prescription.</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Full automation group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <description>The dosage is modified automatically by the device or according to the new medical prescription.</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Full automation group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled surgery for at least one hour

          -  Consent for participation

          -  Affiliation to the social security system

        Exclusion Criteria:

          -  Pregnant or breastfeeding women

          -  Patients for which Conox monitor should not be used

          -  Allergies to propofol or remifentanil
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Fischler, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Foch</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service d'Anesthésie Réanimation Chirurgicale, CHU Besançon</name>
      <address>
        <city>Besançon</city>
        <state>Bourgogne-Franche-Comté</state>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service d'Anesthésie, Hôpital Foch</name>
      <address>
        <city>Suresnes</city>
        <state>Ile De France</state>
        <zip>92151</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service d'Anesthésie du Centre Clinical</name>
      <address>
        <city>Soyaux</city>
        <state>Poitou-Charentes</state>
        <zip>16800</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Liu N, Chazot T, Hamada S, Landais A, Boichut N, Dussaussoy C, Trillat B, Beydon L, Samain E, Sessler DI, Fischler M. Closed-loop coadministration of propofol and remifentanil guided by bispectral index: a randomized multicenter study. Anesth Analg. 2011 Mar;112(3):546-57. doi: 10.1213/ANE.0b013e318205680b. Epub 2011 Jan 13.</citation>
    <PMID>21233500</PMID>
  </results_reference>
  <results_reference>
    <citation>Jensen EW, Valencia JF, López A, Anglada T, Agustí M, Ramos Y, Serra R, Jospin M, Pineda P, Gambus P. Monitoring hypnotic effect and nociception with two EEG-derived indices, qCON and qNOX, during general anaesthesia. Acta Anaesthesiol Scand. 2014 Sep;58(8):933-41. doi: 10.1111/aas.12359. Epub 2014 Jul 4.</citation>
    <PMID>24995461</PMID>
  </results_reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>May 6, 2018</study_first_submitted>
  <study_first_submitted_qc>May 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2018</study_first_posted>
  <last_update_submitted>December 27, 2019</last_update_submitted>
  <last_update_submitted_qc>December 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anesthesia, general</keyword>
  <keyword>Total intravenous anesthesia</keyword>
  <keyword>Closed loop anesthesia</keyword>
  <keyword>Conox</keyword>
  <keyword>EEG monitoring</keyword>
  <keyword>qCon</keyword>
  <keyword>qNox</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

